Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor

Interventions

DRUG: R-(-)-gossypol acetic acid
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)